Skip to content

Agilon Health AGL Additional Paid-In Capital

Additional Paid-In Capital at other companies

Astrana Health logo
Astrana HealthASTH
$477.51M+5.5%
Privia Health Group, Inc. logo
Privia Health Group, Inc.PRVA
$905.05M+8.6%
Alignment Healthcare logo
Alignment HealthcareALHC
$1.2B+7.0%
Clover Health Investments logo
Clover Health InvestmentsCLOV
$2.7B+3.5%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$536.3M-1.7%
Elevance Health logo
Elevance HealthELV
$8.85B-0.2%

Other financials

Income statement

See full
Revenue$1.4B-7.3%
Operating income$4.0M+118%
Net income$48.9M+304%
EPS (diluted)$2.94+303%

Balance sheet

See full
Cash & equivalents$211.6M+52.6%
Total debt$33.4M-20.5%
Total equity$181.4M-63.7%
Total assets$1.5B-22.1%

Cash flow

See full
Operating cash flow$23.7M+174%
CapEx$3.1M-19.4%
Free cash flow$20.6M+158%

Valuation

See full
Market cap$1.86B-92.6%
Enterprise value$1.69B-103%
P/S0.3×-3.9×

Profitability

See full
Operating margin-7.5%+6.5pp
Net margin-6.1%+6.3pp
FCF margin-1.1%

Returns & leverage

See full
Return on equity-104%-291pp
Debt / equity0.2×+0.1×
Current ratio-0.2×

Where this comes from

Reported directly by Agilon Health in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilon Health's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agilon Health's additional paid-in capital?
Agilon Health (AGL) reported additional paid-in capital of $2.11B in Q1 2026.
How has Agilon Health's additional paid-in capital changed year-over-year?
Agilon Health's additional paid-in capital increased by 1.9% year-over-year, from $2.07B to $2.11B.
What is the long-term trend for Agilon Health's additional paid-in capital?
Over 5 years (2020 to 2025), Agilon Health's additional paid-in capital has grown at a 51.5% compound annual growth rate (CAGR), from $263.97M to $2.1B.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.